Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services, today announced the launch of its Comprehensive ...

The cause of death for 39-year-old actress Michelle Trachtenberg has been revealed as related to diabetes complications, ...